Both in Pharmaceuticals
MacroGenics vs AN2 Therapeutics
Over the past year MGNX returned +45.3% and ANTX returned +262.6%; their daily moves had a correlation of 0.17.
MGNX +45.3% ANTX +262.6%Growth of $1, one year, split-adjusted
| Metric | MGNX | ANTX |
|---|---|---|
| Price | $2.30 | $4.17 |
| Market cap | $146.2M | $157.4M |
| Today | −1.50% | −0.24% |
| 1 month | −37.0% | −17.8% |
| 6 months | −23.8% | −10.3% |
| Year to date | +42.5% | +265.8% |
| 1 year | +45.3% | +262.6% |
| Revenue growth (YoY) | +378.0% | — |
| Gross margin | 100.0% | — |
| Net margin | 59.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $173.3M | $78.4M |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | 75.1% |
| Short % of float | 8.2% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).